Trials / Unknown
UnknownNCT04238039
Ketamine Long Therm Follow Up Study
Five Years Follow up: Add on Intravenous Ketamine for Major Depressive Disorder
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (estimated)
- Sponsor
- The Chaim Sheba Medical Center · Academic / Other
- Sex
- All
- Age
- 90 Years
- Healthy volunteers
- Not accepted
Summary
Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.
Detailed description
Anamnestic data will be collected from the patients, in addition, depressive symptoms will be measured using Montgomery Asberg Depression Scale (MADRAS). In addition, the Clinical Global Severity Scale (CGI-S) and Clinical Global Improvement (CGI-I) were performed 2 hours after treatment. In addition, we performed to prolong the time to relapse in this patient.
Conditions
Timeline
- Start date
- 2019-12-14
- Primary completion
- 2020-02-01
- Completion
- 2020-04-01
- First posted
- 2020-01-23
- Last updated
- 2020-01-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04238039. Inclusion in this directory is not an endorsement.